Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)
Public trial records describe studies evaluating LY3437943 in obesity, overweight, and related metabolic conditions
these are distinct populations and the results should not be conflated
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)
Following patent expiration, generic formulations entered the market, and cash-pay prices dropped to approximately $25 to $100 per month through discount pharmacies, manufacturer programs, and compounding pharmacies offering liraglutide preparations
Speaking to a UK Healthcare Professional About These Treatments Patients interested in these treatments should speak to their GP or an obesity medicine specialist, who can assess eligibility for licensed therapies or clinical trials via NHS Tier 3 weight management services
